John W. Glod, M.D.

Dr. John Glod
Associate Research Physician
Pediatric Oncology Branch
Clinical Director

Team Member of:

Katherine E. Warren, M.D.
Brigitte C. Widemann, M.D.

Dr. Glod's research interests include pediatric tumors of the central nervous system, multiple endocrine neoplasia-related medullary thyroid cancer, and neurofibromatosis-related tumors.

Areas of Expertise
1) tumors of the central nervous system, 2) medullary thyroid cancer, 3) neurofibromatosis-related tumors

Contact Info

John W. Glod, M.D.
Center for Cancer Research
National Cancer Institute
Building 10-CRC, Room 1-5750
Bethesda, MD 20892-1100
Ph: 301-451-0391
john.glod@nih.gov
Permalink

Selected Recent Publications

  1. CNS lymphoma in a patient with Shwachman Diamond syndrome.
    Sharma A, Sadimin E, Drachtman R, Glod J.
    Pediatr Blood Cancer. 61: 564-6. , 2014. [ Journal Article ]
  2. P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms.
    Lin SY, Dolfi SC, Amiri S, Li J, Budak-Alpdogan T, Lee KC, Derenzo C, Banerjee D, Glod J.
    Int. J. Oncol. 43: 1817-23, 2013. [ Journal Article ]
  3. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.
    Anton K, Banerjee D, Glod J.
    PLoS ONE. 7: e35036, 2012. [ Journal Article ]
  4. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.
    Medina DJ, Goodell L, Glod J, Gélinas C, Rabson AB, Strair RK.
    Haematologica. 97: 1255-63, 2012. [ Journal Article ]
  5. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.
    Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D.
    Exp. Cell Res . 318: 326-35, 2012. [ Journal Article ]

Dr. Glod obtained his M.D. and Ph.D. from the University of Colorado in Denver and trained in pediatrics and pediatric oncology at Cincinnati Children’s Hospital, Johns Hopkins Hospital, and the Pediatric Oncology Branch of the NCI.  Following an fellowship in neuro-oncology at the NCI, Dr. Glod served as faculty in the departments of pediatrics and pharmacology at Rutgers Cancer Institute of New Jersey. Dr. Glod joined the Pharmacology and Experimental Therapeutics Section in 2013.  His research interests include pediatric tumors of the central nervous system, multiple endocrine neoplasia-related medullary thyroid cancer, and neurofibromatosis-related tumors.

Name Position
Melissa Amaya RN Nurse Specialist
Alissa Baker M.D. Clinical Fellow
Haven Battles Clinical Support Assistant (Contr)
Amanda Carbonell RN Nurse Specialist
Julia Cohen M.D. Clinical Fellow
Andrea Cuviello M.D. Clinical Fellow
Cindy Delbrook RN Senior Nurse Specialist
Sherri DePollar Patient Care Coordinator
Joanne Derdak N.P. Nurse Practitioner
Yiouli Ktena M.D. Clinical Collaborator
Bonnie Lau M.D. Clinical Fellow
Emily Limerick M.D. Clinical Fellow
Micah Maxwell M.D., Ph.D. Clinical Fellow
Terri Moore Patient Care Coordinator (Contr)
Kristen Schratz M.D. Clinical Fellow
Nirali Shah M.D. Staff Clinician
Haneen Shalabi D.O. Clinical Fellow
David J. Young M.D., Ph.D. Clinical Collaborator